Table 4. The area under the curve (AUC) measures.

Variable	CG (%) (N = 31)	TG (%) (N = 30)	p-value
Log CRP
AUC1–14 (day × mg/L)	16.2 ± 8.7	19.5 ± 12.3	0.2
Log ESR
AUC1–14 (day × mm/h)	35.8 ± 7.8	33.6 ± 11.8	0.4
Log IL-6
AUC1–14 (day × pg/ml)	10.2 ± 7.9	13.7 ± 7.1	0.1
Log IL-1β
AUC1–14 (day × pg/ml)	11.8 ± 5.6	10.8 ± 5.0	0.5
Log TNF-α
AUC1–14 (day × pg/ml)	24.4 ± 16.8	23.9 ± 15.4	0.9
Log S100B
AUC1–14 (day × pg/ml)	39.4 ± 18.2	40.7 ± 15.8	0.9

CG: control group; TG: treatment group; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; IL-6: interleukin-6; IL-1β: interleukin-1β; TNF-α: tumor necrosis factor-α; S100B: S100B protein; AUC 1–14: AUC from baseline to day 14 after PG2 treatment; independent test for continuous data.